# Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer

> **NCT01419002** · PHASE3 · TERMINATED · sponsor: **CHIR-Net** · enrollment: 5 (actual)

## Conditions studied

- Pancreatic Adenocarcinoma

## Interventions

- **RADIATION:** neoadjuvant RTx
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT01419002
- **Lead sponsor:** CHIR-Net
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** lack of recruitment
- **Last updated:** 2015-07-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01419002

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01419002, "Study to Evaluate if Neoadjuvant Radiotherapy Improves Recurrence Free Survival in Pancreatic Head Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01419002. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*